NEW YORK (GenomeWeb) – The Perelman School of Medicine at the University of Pennsylvania has received a $7.3 million grant from the National Cancer Institute for three research projects targeting genes and proteins involved in of esophageal cancer.

The grant renews an NCI-funded program at the Perelman school that has been ongoing for 10 years, and is the only program of its kind that NCI supports that is focused on finding treatments and biomarkers for esophageal cancer, the medical school said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.